These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19930042)

  • 1. Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.
    Katsara M; Yuriev E; Ramsland PA; Tselios T; Deraos G; Lourbopoulos A; Grigoriadis N; Matsoukas J; Apostolopoulos V
    Immunology; 2009 Dec; 128(4):521-33. PubMed ID: 19930042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
    Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
    Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2.
    Katsara M; Yuriev E; Ramsland PA; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    Mol Immunol; 2008 Aug; 45(13):3661-70. PubMed ID: 18541301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.
    Katsara M; Deraos G; Tselios T; Matsoukas MT; Friligou I; Matsoukas J; Apostolopoulos V
    J Med Chem; 2009 Jan; 52(1):214-8. PubMed ID: 19072222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic citrullinated MBP
    Apostolopoulos V; Deraos G; Matsoukas MT; Day S; Stojanovska L; Tselios T; Androutsou ME; Matsoukas J
    Bioorg Med Chem; 2017 Jan; 25(2):528-538. PubMed ID: 27908754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.
    Jiang H; Braunstein NS; Yu B; Winchester R; Chess L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6301-6. PubMed ID: 11353822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.
    Karin N; Mitchell DJ; Brocke S; Ling N; Steinman L
    J Exp Med; 1994 Dec; 180(6):2227-37. PubMed ID: 7525850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.
    Katsara M; Yuriev E; Ramsland PA; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Neuroimmunol; 2008 Aug; 200(1-2):77-89. PubMed ID: 18675465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
    Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
    Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
    Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
    Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy.
    Gaur A; Wiers B; Liu A; Rothbard J; Fathman CG
    Science; 1992 Nov; 258(5087):1491-4. PubMed ID: 1279812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F; Mason D
    Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma.
    Adlard K; Tsaknardis L; Beam A; Bebo BF; Vandenbark AA; Offner H
    Autoimmunity; 1999; 31(4):237-48. PubMed ID: 10789989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.